Light therapy study for nerve pain from cancer treatment
Part of Brain & nervous system clinical trials.
This test uses a light device (photobiomodulation) to see if it can help prevent or reduce nerve damage and pain caused by chemotherapy. It is for patients starting cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are about to start or are currently receiving cancer treatment at a day hospital
- You do not have a serious memory, thinking, or mental health condition that would make it hard to take part
- You can understand the study information and give your permission (informed consent)
- You do not have nerve damage or pain before starting chemotherapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether light (photobiomodulation) and laser-like therapy can reduce nerve pain in people who developed neuropathy after chemotherapy. If you match the chemotherapy and language requirements, you may be screened to see if this treatment is safe and helpful for your symptoms.
This study tests whether shining light on the feet and legs can help reduce nerve damage caused by chemotherapy in people who had cancer as children. If you have ongoing numbness, tingling, or pain in your hands or feet from past chemo, this trial may offer a gentle, drug-free treatment.
This study tests whether a small device that sends gentle electrical pulses to nerves in your leg can relieve pain caused by chemotherapy. If you have ongoing nerve pain in your legs from past chemo, this treatment might offer a new way to manage it.
This study tests whether a gentle, non-invasive brain stimulation (over the motor cortex) can help relieve pain caused by nerve damage from chemotherapy. It is for people who have completed cancer treatment at least 3 months ago and have ongoing painful neuropathy.
This study tests a new gel (VMD-3866) applied to the skin to treat moderate nerve pain, numbness, or tingling caused by previous chemotherapy. It aims to see if the gel can safely reduce pain for people whose symptoms have been stable for at least 8 weeks.
This trial tests whether spinal cord stimulation can reduce pain and improve quality of life in people with long-lasting nerve pain from chemotherapy (CIPN). You must already have tried at least two nerve-pain medicines and still have significant pain, and you must have had a successful spinal cord stimulator test before joining.
Hear when a new Chemotherapy-induced Peripheral Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.